Anzeige
Mehr »
Login
Donnerstag, 02.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
"Special Situation"-Aktie mit Multi-Tenbagger-Potenzial im heißesten Rohstoff-Markt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
21 Leser
Artikel bewerten:
(0)

Allscripts to Announce Fiscal Fourth Quarter and Year-End Results / Company to Host Conference Call After Market Close on July 20, 2010

CHICAGO, June 24 /PRNewswire-FirstCall/ -- Allscripts announced today that it will report its financial results for the three months and fiscal year ended May 31, 2010 after the stock market closes on Tuesday, July 20, 2010. Allscripts management will host a conference call and webcast to discuss the company's earnings and other information at 4:30 PM Eastern Daylight Time on the same day.

(Logo: http://photos.prnewswire.com/prnh/20081013/AQM041LOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO)

The earnings announcement will be distributed via PR Newswire immediately after the market closes on the afternoon of July 20, 2010. The press release also will be available on the company's website at http://www.allscripts.com/.

To listen to the conference call, participants may log onto http://www.allscripts.com/. Participants are encouraged to log onto the website approximately 15 minutes prior to the start of the conference call to download and install any necessary software. Participants also may access the conference call by dialing 877-303-0543 (in the U.S.) or 973-935-8787 (international) and requesting conference ID # 83092447. A replay of the call will be available three hours after the conclusion of the call, for a period of two weeks, at http://www.allscripts.com/ or by calling 800-642-1687 or 706-645-9291 - conference ID # 83092447.

(Minimum requirements to listen to the call online are: Microsoft Windows Media Player software, downloadable free from http://windowsmedia.com/download/download.asp, an Internet connection, and speakers or earphones).

About Allscripts

Allscripts uses innovation technology to bring health to healthcare. More than 160,000 physicians, 800 hospitals and more than 10,000 post-acute and homecare organizations utilize Allscripts to improve the health of their patients and their bottom line. The company's award-winning solutions include Electronic Health Record, Electronic Prescribing, Revenue Cycle Solutions, Practice Management, Document Management, Care Management, Emergency Department Information Systems and Homecare automation. Allscripts is the brand name of Allscripts-Misys Healthcare Solutions, Inc. To learn more, visit http://www.allscripts.com/.

For more Allscripts news, follow us on Twitter at: http://twitter.com/AllscriptsMisys

This news release may contain forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future are forward-looking statements within the meaning of these laws. These forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, actual results may vary materially from those anticipated by the forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: the volume and timing of systems sales and installations; length of sales cycles and the installation process; the possibility that products will not achieve or sustain market acceptance; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; competitive pressures including product offerings, pricing and promotional activities; our ability to establish and maintain strategic relationships; undetected errors or similar problems in our software products; compliance with existing laws, regulations and industry initiatives and future changes in laws or regulations in the healthcare industry; possible regulation of the Company's software by the U.S. Food and Drug Administration; the possibility of product-related liabilities; our ability to attract and retain qualified personnel; our ability to identify and complete acquisitions, manage our growth and integrate acquisitions; the ability to recognize the benefits of the merger with Misys Healthcare Systems, LLC ("MHS"); the integration of MHS with the Company and the possible disruption of current plans and operations as a result thereof; maintaining our intellectual property rights and litigation involving intellectual property rights; risks related to third-party suppliers; our ability to obtain, use or successfully integrate third-party licensed technology; breach of our security by third parties; and the risk factors detailed from time to time in our reports filed with the Securities and Exchange Commission, including our 2009 Annual Report on Form 10-K available through the Web site maintained by the Securities and Exchange Commission at http://www.sec.gov/. The Company undertakes no obligation to update publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

Photo: http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO
AP Archive: http://photoarchive.ap.org/
http://photos.prnewswire.com/prnh/20081013/AQM041LOGO
PRN Photo Desk, photodesk@prnewswire.com

Allscripts-Misys Healthcare Solutions, Inc.

CONTACT: CONTACT: Seth Frank, Vice President, Investor Relations,
+1-312-506-1213, seth.frank@allscripts.com, or Todd Stein, Senior
Manager/Public Relations, +1-312-506-1216, todd.stein@allscripts.com, both of
Allscripts-Misys Healthcare Solutions, Inc.

Web Site: http://www.allscripts.com/

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2010 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.